Piekos Brian 4
4 · KalVista Pharmaceuticals, Inc. · Filed Feb 25, 2025
Insider Transaction Report
Form 4
Piekos Brian
Chief Financial Officer
Transactions
- Award
Restricted Stock Unit
2025-02-21+80,000→ 80,000 total→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
- [F2]3/16th of the total number of shares underlying the RSUs shall vest on November 21, 2024 and 1/16 shall vest on each quarterly anniversary of the Vesting Commencement Date thereafter, for so long as grantee's Service (as defined in the Plan) does not terminate.